Latest AI and machine learning research in liver transplantation for healthcare professionals.
BACKGROUND: Differentiating among liver disease entities such as autoimmune liver disease (AILD), drug-induced liver injury (DILI), and chronic hepatitis B (CHB) remains clinically challenging due to overlapping clinical manifestations and nonspecific laboratory findings. Conventional machine learning (ML) approaches rely mainly on structured laboratory data, whereas free-text clinical reports and...
Multiple myeloma (MM) is a malignant blood cancer marked by severe bone destruction and immune microenvironment disruption. Yet relapse and drug resistance remain major clinical challenges. Tanshinone IIA (TIIA) exhibits potent antitumor activity, but its molecular targets and mechanisms in MM remain unclear. Here, we systematically elucidate TIIA's pharmacological mechanisms in MM using network p...
To explore the role of N4-acetylcytidine (ac4C)-related genes (acRGs) in colon adenocarcinoma (COAD) and identify reliable prognostic biomarkers and p...
Cancer cells exhibit metabolic reprogramming, most notably the Warburg effect, which underscores their heightened dependency on glucose uptake facilit...
BACKGROUND: MASLD is the most prevalent chronic liver disease worldwide, with pooled global prevalence estimates of approximately 30%. Current noninva...
BACKGROUND: Renal transplantation is the preferred treatment for end-stage chronic kidney disease but requires lifelong immunosuppression, increasing ...
Solid tumors, the most prevalent form of malignancy, pose therapeutic challenges distinct from hematologic malignancies due to their complex biology, ...
PURPOSE: Liver fibrosis and cirrhosis represent critical stages in the progression of chronic liver disease, yet their key molecular features remain i...
Xenotransplantation represents a potential solution to the persistent global organ shortage, yet its clinical application remains stalled by complex i...
Noninvasive identification of advanced liver fibrosis (ALF), commonly defined as Scheuer stage S3 or higher, is important for the management of patien...
The hepatitis C virus is a significant global health concern and a major cause of chronic liver disease. Therefore, developing a mathematical model is...
Chronic liver diseases are an increasing cause of morbidity and mortality in Latin America, driven by the convergence of alcohol and metabolic-associa...
BACKGROUND: Accurate risk stratification for hepatocellular carcinoma (HCC) among chronic hepatitis B (CHB) patients remains challenging. Vibration-co...
BACKGROUND: Anorexia nervosa (AN) is frequently accompanied by metabolic disturbances and immune dysregulation, yet its peripheral molecular mechanism...
Polytrauma is commonly defined as multisystem trauma involving at least two body regions with an Abbreviated Injury Scale (AIS) score ≥ 3, characteriz...
INTRODUCTION: Vancomycin is widely used for severe Gram‑positive infections in children, but vancomycin‑induced nephrotoxicity (VIN) limits its safe a...
Hepatitis B virus-like particles (HBV-VLPs), characterized by precise biomimetic topological architecture and favorable biocompatibility, have become ...
INTRODUCTION: Latin America occupies a paradoxical position in hepatitis B virus (HBV) elimination: aggregate prevalence is low, yet the region remain...
PURPOSE: Delayed graft function (DGF) remains a significant complication following deceased donor kidney transplantation. This study aimed to develop ...
BACKGROUND: Hepatocellular carcinoma (HCC) is characterized by marked heterogeneity and an immunosuppressive microenvironment in which tumor-associate...